The Classical subtype of GBM is recognized by epidermal growth factor (EGFR) amplifications, and the overexpression of EGFR has been associated with elevated levels of phosphorylated ERK1/2, possibly indicating increased levels or activity MEK1/241. This evidence concerns the gene MAPK3 and glioblastoma.